Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Liabilities and Shareholders Equity: 2021

Historic Liabilities and Shareholders Equity for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to $119.8 million.

  • Milestone Pharmaceuticals' Liabilities and Shareholders Equity fell 35.89% to $85.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $402.7 million, marking a year-over-year change of. This contributed to the annual value of $119.8 million for FY2021, which is N/A change from last year.
  • As of FY2021, Milestone Pharmaceuticals' Liabilities and Shareholders Equity stood at $119.8 million.
  • Milestone Pharmaceuticals' 5-year Liabilities and Shareholders Equity high stood at $119.8 million for FY2021, and its period low was $119.8 million during FY2021.
  • Over the past 1 years, Milestone Pharmaceuticals' median Liabilities and Shareholders Equity value was $119.8 million (recorded in 2021), while the average stood at $119.8 million.